176 related articles for article (PubMed ID: 28628558)
1. Genetics of pleiotropic effects of dexamethasone.
Ramsey LB; Pounds S; Cheng C; Cao X; Yang W; Smith C; Karol SE; Liu C; Panetta JC; Inaba H; Rubnitz JE; Metzger ML; Ribeiro RC; Sandlund JT; Jeha S; Pui CH; Evans WE; Relling MV
Pharmacogenet Genomics; 2017 Aug; 27(8):294-302. PubMed ID: 28628558
[TBL] [Abstract][Full Text] [Related]
2. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.
Karol SE; Yang W; Van Driest SL; Chang TY; Kaste S; Bowton E; Basford M; Bastarache L; Roden DM; Denny JC; Larsen E; Winick N; Carroll WL; Cheng C; Pei D; Fernandez CA; Liu C; Smith C; Loh ML; Raetz EA; Hunger SP; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Mattano LA; Relling MV
Blood; 2015 Oct; 126(15):1770-6. PubMed ID: 26265699
[TBL] [Abstract][Full Text] [Related]
3. A
Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
[TBL] [Abstract][Full Text] [Related]
5. ALL and osteonecrosis.
Gaynon PS
Blood; 2015 Oct; 126(15):1734-5. PubMed ID: 26450951
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
[TBL] [Abstract][Full Text] [Related]
7. Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.
Karol SE; Janke LJ; Panetta JC; Ramsey LB; Cai X; Payton MA; Jenkins DA; Evans WE; Relling MV
PLoS One; 2019; 14(5):e0216328. PubMed ID: 31059548
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Levien MG
Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
[No Abstract] [Full Text] [Related]
9. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
Ramsey LB; Janke LJ; Payton MA; Cai X; Paugh SW; Karol SE; Kamdem Kamdem L; Cheng C; Williams RT; Jeha S; Pui CH; Evans WE; Relling MV
PLoS One; 2015; 10(8):e0135134. PubMed ID: 26252865
[TBL] [Abstract][Full Text] [Related]
10. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.
Finch ER; Janke LJ; Smith CA; Karol SE; Pei D; Cheng C; Kaste SC; Inaba H; Pui CH; Wolf J; Relling MV
Pediatr Blood Cancer; 2019 Jun; 66(6):e27669. PubMed ID: 30758124
[TBL] [Abstract][Full Text] [Related]
12. Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.
Shinohara T; Urayama KY; Watanabe A; Akahane K; Goi K; Huang M; Kagami K; Abe M; Sugita K; Okada Y; Goto H; Minegishi M; Iwamoto S; Inukai T
J Cell Mol Med; 2020 Nov; 24(22):12920-12932. PubMed ID: 33002292
[TBL] [Abstract][Full Text] [Related]
13. Bony morbidity in children treated for acute lymphoblastic leukemia.
Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
[TBL] [Abstract][Full Text] [Related]
14. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
[No Abstract] [Full Text] [Related]
15. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
17. A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.
Park HW; Tse S; Yang W; Kelly HW; Kaste SC; Pui CH; Relling MV; Tantisira KG
Pharmacogenomics J; 2017 Mar; 17(2):180-185. PubMed ID: 26856247
[TBL] [Abstract][Full Text] [Related]
18. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
[TBL] [Abstract][Full Text] [Related]
19. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
[TBL] [Abstract][Full Text] [Related]
20. Time course of recovery of adrenal function in children treated for leukemia.
Felner EI; Thompson MT; Ratliff AF; White PC; Dickson BA
J Pediatr; 2000 Jul; 137(1):21-4. PubMed ID: 10891816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
